Intuitive Surgical, Inc. (ISRG)
NASDAQ: ISRG · Real-Time Price · USD
466.64
-4.35 (-0.92%)
At close: Apr 28, 2026, 4:00 PM EDT
464.00
-2.64 (-0.57%)
After-hours: Apr 28, 2026, 5:32 PM EDT
Intuitive Surgical Stock Forecast
Stock Price Forecast
The 19 analysts with 12-month price forecasts for Intuitive Surgical stock have an average target of 591.32, with a low estimate of 440 and a high estimate of 750. The average target predicts an increase of 26.72% from the current stock price of 466.64.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Intuitive Surgical stock from 19 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 6 | 3 | 4 | 4 | 5 | 6 |
| Buy | 8 | 7 | 7 | 7 | 7 | 8 |
| Hold | 2 | 3 | 3 | 4 | 3 | 4 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Total | 17 | 14 | 15 | 16 | 16 | 19 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Buy Maintains $712 → $651 | Buy | Maintains | $712 → $651 | +39.51% | Apr 23, 2026 |
| Leerink Partners | Leerink Partners | Buy Maintains $622 → $573 | Buy | Maintains | $622 → $573 | +22.79% | Apr 22, 2026 |
| Baird | Baird | Buy Maintains $575 → $610 | Buy | Maintains | $575 → $610 | +30.72% | Apr 22, 2026 |
| Piper Sandler | Piper Sandler | Buy Maintains $620 → $580 | Buy | Maintains | $620 → $580 | +24.29% | Apr 22, 2026 |
| BTIG | BTIG | Strong Buy Reiterates $574 | Strong Buy | Reiterates | $574 | +23.01% | Apr 22, 2026 |
Financial Forecast
Revenue This Year
11.74B
from 10.06B
Increased by 16.64%
Revenue Next Year
13.37B
from 11.74B
Increased by 13.91%
EPS This Year
10.22
from 7.87
Increased by 29.85%
EPS Next Year
11.66
from 10.22
Increased by 14.14%
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 12.4B | 14.5B | ||||||
| Avg | 11.7B | 13.4B | ||||||
| Low | 11.0B | 12.1B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 23.0% | 23.1% | ||||||
| Avg | 16.6% | 13.9% | ||||||
| Low | 9.0% | 3.0% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 11.18 | 12.88 | |||
| Avg | 10.22 | 11.66 | |||
| Low | 9.51 | 10.59 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 42.1% | 26.0% | |||
| Avg | 29.8% | 14.1% | |||
| Low | 20.8% | 3.7% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.